Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Targeting Keratin 17 may help overcome cancer therapy resistance.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Basal cell carcinoma shows keratin patterns similar to undifferentiated hair follicle cells.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

B cells can both help and hinder the body's defense against melanoma.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.